Quarterly Earnings

A revolutionary single-dose, over-the-counter cold sore tablet launches in Europe, promising new convenience for millions and shaking up the self-care market.

Quanex will report Q2 results on June 4, with investors watching for updates on its Tyman integration and performance in a tough building market.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

Dream Finders Homes escalates its takeover attempt of Beazer Homes with a public offer, citing a decade of underperformance and a failing strategy.

The electronics giant reports lower revenue and profit for FY2026, citing tariffs and global uncertainty, yet boosts margins and bets on innovation.

The private markets giant announced a dividend hike and expanded buyback after a stellar fiscal year, crossing the $1 trillion asset milestone.

As X Financial prepares its Q1 2026 results, investors are watching closely after a tough Q4 and amid China's harsh new fintech regulations.

After a record 2025, investors are watching if UP Fintech can sustain its growth amid global market turmoil and rising interest rates.

With a new $1 billion credit facility, Curtiss-Wright has the financial firepower to accelerate its 'Pivot to Growth' through strategic acquisitions.

AB Akola Group's latest results show a strategic success, as booming food production profits offset severe downturns in its traditional farming segments.

Fresh off a stellar quarter, Everus Construction Group heads to key conferences to detail its role in powering data centers and America's energy transition.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

As graphene leader NanoXplore appoints CEO Rocco Marinaccio to its board, the move signals a push for faster growth but raises timeless governance questions.

With a key earnings report and investor conference ahead, all eyes are on Ulta Beauty to prove its resilience in a rapidly evolving retail landscape.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

A sharp drop in new work truck availability is hitting businesses hard, with new data linking the supply crunch to recent tariffs and rising used vehicle costs.

NextNRG reports a 56% revenue surge driven by AI-optimized fueling, but a closer look reveals a high-stakes bet on future energy infrastructure.

Newly public Yesway faces its first major test with its Q1 earnings. Investors will scrutinize if its aggressive expansion can meet high analyst expectations.

Natural Alternatives International posts a 23% sales surge but a wider net loss, betting on new financing and product innovation to fix profitability woes.

The Chinese gaming giant signals confidence with a major share repurchase, but is it a growth strategy or a defensive play in a challenging market?